Growth Metrics

Tandem Diabetes Care (TNDM) Operating Income Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -20.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.83%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.06%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 19.54%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 20.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 74.18%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 90.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -18.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 46.60%
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn 85.58%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 85.58%
Dec 31, 2025 1,527.54%
Sep 30, 2025 12.38%
Jun 30, 2025 -68.36%
Mar 31, 2025 -190.03%
Dec 31, 2024 98.34%
Sep 30, 2024 17.28%
Jun 30, 2024 20.70%
Mar 31, 2024 67.39%
Dec 31, 2023 -97.22%
Sep 30, 2023 33.58%
Jun 30, 2023 -217.08%
Mar 31, 2023 -733.34%
Dec 31, 2022 -239.56%
Sep 30, 2022 -715.19%
Jun 30, 2022 -325.31%
Mar 31, 2022 -373.83%
Dec 31, 2021 -31.74%
Sep 30, 2021 865.11%
Jun 30, 2021 145.13%
Mar 31, 2021 76.15%
Dec 31, 2020 770.43%
Sep 30, 2020 83.19%
Jun 30, 2020 -545.42%
Mar 31, 2020 -23.42%
Dec 31, 2019 282.86%
Sep 30, 2019 61.78%
Jun 30, 2019 86.68%
Mar 31, 2019 28.98%
Dec 31, 2018 105.84%
Sep 30, 2018 -19.31%
Jun 30, 2018 26.21%
Mar 31, 2018 27.05%
Dec 31, 2017 28.20%
Sep 30, 2017 53.66%
Jun 30, 2017 -11.24%
Mar 31, 2017 -10.33%
Dec 31, 2016 -18.94%
Sep 30, 2016 -51.92%
Jun 30, 2016 8.67%
Mar 31, 2016 5.74%
Dec 31, 2015 35.89%
Sep 30, 2015 1.60%
Jun 30, 2015 -1.93%
Mar 31, 2015 2.05%
Dec 31, 2014 -6.31%
Sep 30, 2014 -56.73%
Jun 30, 2014 -33.93%
Mar 31, 2014 -190.74%